Variation in the CYSLTR1 gene modulates asthma risk as well as adenoid hypertrophy progression, and it has been implicated in the disease outcome of colorectal, prostate, and squamous cell carcinoma 17-21. This evidence concerns the gene CYSLTR1 and squamous cell carcinoma.